Endothelial glycocalyx hyaluronan: regulation and role in prevention of diabetic complications.
Clicks: 342
ID: 93297
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
342 views
42 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #9 of 9 articles by views in the american journal of pathology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The endothelial glycocalyx is critically involved in vascular integrity and homeostasis, by regulating vascular permeability, mechanotransduction, and reducing inflammation and coagulation. The turnover of the glycocalyx is very dynamic to fine-tune these processes. This is in particular true for its main structural component hyaluronan (HA). Degradation and shedding of the glycocalyx by enzymes, such as hyaluronidase 1 and hyaluronidase 2, are responsible for regulation of the glycocalyx thickness and hence access of circulating cells and factors to the endothelial cell membrane and its receptors. This degradation process will at the same time also allow for re-synthesis and adaptive chemical modification of the glycocalyx. The (re)synthesis of HA is dependent on the availability of its sugar substrates, thus linking glycocalyx biology directly to cellular glucose metabolism. It is therefore of particular interest to consider the consequences of dysregulated cellular glucose in diabetes for glycocalyx biology and its implications for endothelial function. This review summarizes the metabolic regulation of endothelial glycocalyx HA and its potential as a therapeutic target in diabetic vascular complications.
| Reference Key |
wang2020endothelialthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Wang, Gangqi;Tiemeier, Gesa L;van den Berg, Bernard M;Rabelink, Ton J; |
| Journal | the american journal of pathology |
| Year | 2020 |
| DOI |
S0002-9440(20)30070-5
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.